Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.

Diabetol Metab Syndr · 2022 · PMC9585736 · PMID 36271423

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Additionally, any apparent increased risks of cholelithiasis (RR 0.73 [95% CI 0.35–1.50]), cholangitis (RR 0.69 [95% CI 0.27–1.78]), bile duct stones (RR 0.87 [95% CI 0.39–1.95]), and biliary colic (RR 0.77 [95% CI 0.20–2.96]) did not reach statistical significance (Fig. 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.